Table 3.

Comparisons of characteristics between the intraretinal hemorrhage group and non-intraretinal hemorrhage group.

Characteristics	IRH group (n = 19)	Non-IRH group (n = 27)	P-value
Age, years	77.8 ± 8.9	77.3 ± 7.8	0.858*
Male:female	7 (36.8%):12 (63.2%)	4 (14.8%):23 (85.2%)	0.159†
Diabetes mellitus	1 (5.3%)	2 (7.4%)	1.000†
Hypertension	13 (68.4%)	18 (66.7%)	0.901‡
Use of anticoagulants	4 (21.1%)	8 (29.6%)	0.735†
Blood pressure, mmHg
Systolic	136.8 ± 14.9	141.4 ± 16.9	0.515*
Diastolic	75.5 ± 11.3	76.5 ± 12.2	0.946*
Extent of hemorrhage, disc areas	10.7 ± 5.2	7.1 ± 4.3	0.019*
Presence of submacular hemorrhage	16 (84.2%)	9 (33.3%)	0.001‡
Treatment			0.887‡
Intravitreal bevacizumab	13 (68.4%)	19 (70.4%)
Observation	6 (31.6%)	8 (29.6%)
Follow-up period, months	22.6 ± 14.9	26.3 ± 15.9	0.371*

Data are presented as mean ± standard deviation or number (%) where applicable.

IRH intraretinal hemorrhage.

*Statistical analysis was performed using Mann–Whitney U test.

^†Statistical analysis was performed using Fisher’s exact test.

^‡Statistical analysis was performed using chi-square test.